Christopher Richard Anzalone Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 20 hours ago
Christopher Richard Anzalone has an estimated net worth of at least $90.6 million*, as of March 5, 2025. They own 3.8 million shares of ARWR stock. They have sold 888,655 shares of ARWR stock since 2021, for an estimated $25.8 million.
Christopher Richard Anzalone $ARWR SEC Form 4 Insider Trading
Christopher Richard Anzalone has filed a total of 30 insider trades in $ARWR since 2021. Their most recent trade was a sale of 133,333 shares, made on Mar 04, 2025. Their largest trade was a sale of 166,667 shares, made on Mar 03, 2025. We estimate that they now own 3.8 million shares of $ARWR, worth an estimated $64.8 million.
Insider Trading at $ARWR
There have been a total of 160 insider trades reported at $ARWR since 2021, with 3,655 shares purchased and 1.5 million shares sold. The most active insider traders in $ARWR stock have been Christopher Richard Anzalone, Patrick O'Brien, and Kenneth Allen Myszkowski. The most recent trade was a sale of 166,667 shares reported by Christopher Richard Anzalone (Chief Executive Officer), made on Mar 03, 2025.
History of Insider Stock Trades by Christopher Richard Anzalone
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 133,333 | Mar 04, 2025 | March 5, 2025, 7:32 p.m. |
![]() |
Sale | 166,667 | Mar 03, 2025 | March 5, 2025, 7:32 p.m. |
![]() |
Sale | 11,520 | Jan 02, 2025 | Jan. 6, 2025, 7:07 p.m. |
![]() |
Sale | 12,563 | Dec 23, 2024 | Dec. 23, 2024, 5:39 p.m. |
![]() |
Sale | 5,799 | Dec 18, 2024 | Dec. 20, 2024, 7:04 p.m. |
![]() |
Sale | 8,260 | Dec 18, 2024 | Dec. 20, 2024, 7:04 p.m. |
![]() |
Sale | 12,653 | Dec 18, 2024 | Dec. 20, 2024, 7:04 p.m. |
![]() |
Sale | 19,730 | Jan 31, 2024 | Feb. 2, 2024, 6:25 p.m. |
![]() |
Sale | 37,769 | Jan 31, 2024 | Feb. 2, 2024, 6:25 p.m. |
![]() |
Sale | 5,318 | Jan 02, 2024 | Jan. 4, 2024, 6:25 p.m. |
![]() |
Sale | 4,634 | Jan 02, 2024 | Jan. 4, 2024, 6:25 p.m. |
![]() |
Sale | 12,000 | Dec 20, 2023 | Dec. 22, 2023, 6:04 p.m. |
![]() |
Sale | 24,338 | Oct 25, 2023 | Oct. 27, 2023, 6:23 p.m. |
![]() |
Sale | 31,523 | Sep 18, 2023 | Sept. 20, 2023, 6:10 p.m. |
![]() |
Sale | 26,232 | Sep 18, 2023 | Sept. 20, 2023, 6:10 p.m. |
![]() |
Sale | 25,992 | May 04, 2023 | May 5, 2023, 7:04 p.m. |
![]() |
Sale | 54,928 | May 03, 2023 | May 5, 2023, 7:04 p.m. |
![]() |
Sale | 24,008 | May 04, 2023 | May 5, 2023, 7:04 p.m. |
![]() |
Sale | 1,900 | Feb 11, 2022 | Feb. 14, 2022, 9:54 a.m. |
![]() |
Sale | 40,853 | Feb 11, 2022 | Feb. 14, 2022, 9:54 a.m. |
![]() |
Sale | 42,153 | Feb 11, 2022 | Feb. 14, 2022, 9:54 a.m. |
![]() |
Sale | 61,482 | Feb 11, 2022 | Feb. 14, 2022, 9:54 a.m. |
![]() |
Sale | 25,857 | Dec 15, 2021 | Dec. 17, 2021, 9:14 p.m. |
![]() |
Sale | 3,074 | Dec 15, 2021 | Dec. 17, 2021, 9:14 p.m. |
![]() |
Sale | 9,223 | Dec 15, 2021 | Dec. 17, 2021, 9:14 p.m. |
![]() |
Sale | 6,989 | Dec 15, 2021 | Dec. 17, 2021, 9:14 p.m. |
![]() |
Sale | 14,857 | Dec 15, 2021 | Dec. 17, 2021, 9:14 p.m. |
![]() |
Sale | 44,170 | Oct 22, 2021 | Oct. 21, 2021, 8 p.m. |
![]() |
Sale | 15,000 | Oct 20, 2021 | Oct. 21, 2021, 8 p.m. |
![]() |
Sale | 5,830 | Oct 22, 2021 | Oct. 21, 2021, 8 p.m. |
$ARWR Executives and Stock Owners with Insider Trades
-
Christopher Richard Anzalone, Chief Executive Officer
-
Patrick O'Brien, COO and General Counsel
-
Kenneth Allen Myszkowski, Chief Financial Officer
-
Martin Javier San, Chief Medical Officer
-
James C Hamilton, Chief Discovery/Trans Medicine
-
Patrick O'Brien, General Counsel
-
Tracie Oliver, Chief Commercial Officer
-
James Hassard, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.